Posts Tagged: anticompetitive


Antitrust Suit Filed by 36 State AGs Targets Google Anticompetitive Practices on Android App Distribution

Last week, the attorneys general of 36 U.S. states and the District of Columbia filed a lawsuit in the Northern District of California against internet services and …
By Steve Brachmann
3 months ago 2

Trademarks Are Not Patents: The Second Circuit Rejects FTC Challenge to Trademark Settlements in 1-800 Contacts

In “big IP cases that count,” the U.S. Federal Trade Commission (FTC) has had a mixed record lately, going one-for-three – good in baseball but bad in …
By Alden Abbott
3 months ago 0

A Critique of Glory Days and How Reports of Anticompetitive Risks of Pools Have Been Greatly Exaggerated

In a previous article, we laid out the basics of “patent pools”, which license patents that are declared essential for technology standards. A recent article published in …

Anticompetitive or Hyper-Competitive? An Analysis of the FTC v. Qualcomm Oral Argument

On February 13, the Ninth Circuit heard oral argument in the FTC v. Qualcomm case. Counsel for Qualcomm and the Federal Trade Commission (FTC) argued primarily about whether …
By Kristen Osenga
2 years ago 0

Ninth Circuit Told They Should Stay Judge Koh’s Qualcomm Injunction

On July 15, retired Federal Circuit Chief Judge Paul Michel filed an amicus brief in Qualcomm’s appeal of the Federal Trade Commission’s (FTC) antitrust case to …
By Gene Quinn & Steve Brachmann
2 years ago 0

The FTC’s Qualcomm Case Reveals Concerning Divide with DOJ on Patent Hold-Up

On May 2, the Antitrust Division of the U.S. Department of Justice (DOJ) took the unusual step of submitting a Statement of Interest in the Federal Trade …
By Timothy Syrett
2 years ago 0

Long Overdue Victory for the FTC Restores Balance to Standard Essential Patents

In a June 4 op-ed to IPWatchDog, James Edwards launched a scathing attack against Judge Koh and her 233-page ruling, which found Qualcomm to have engaged in anticompetitive …
By Alexander Prenter
2 years ago 0

Affordable Prescriptions for Patients Act Would Allow FTC to Prosecute Pharma Patent Thickets, Product Hopping

On Thursday, May 9, the Affordable Prescriptions for Patients (APP) Act was introduced into the U.S. Senate by Senators John Cornyn (R-TX) and Richard Blumenthal (D-CT). If …
By Steve Brachmann
2 years ago 1

DOJ Antitrust Chief Raises Standard Setting Concerns

Increasingly, Delrahim's speeches are moving past where he began in his USC speech in November 2017, discussing this being the appropriate time to now have a discussion about …
By Gene Quinn
3 years ago 2

Code sues Honeywell at ITC and EDTX for attempting to monopolize barcode reader market

Barcode reading solutions provider Code Corporation of Salt Lake City, UT, announced that it had filed antitrust actions against engineering conglomerate Honeywell International (NYSE:HON) at both …
By Steve Brachmann
4 years ago 20

Broadcom Announces Bid Valued at $130 Billion to Buy American Semiconductor Giant Qualcomm

On Monday, November 6th, Singapore-based semiconductor designer Broadcom (NASDAQ:AVGO) announced that it had offered a proposal to acquire San Diego, CA-based semiconductor rival Qualcomm (NASDAQ:QCOM). …

Qualcomm strikes back, sues Apple for tortious interference and unlawful business tactics

Qualcomm accused Apple of engaging in tortious interference relating to Qualcomm’s licensing activities with Apple’s contract manufacturers. Specifically, Qualcomm asserts that Apple pressured contract manufacturers …
By Steve Brachmann
4 years ago 1

Reverse Payment Settlements and Holdup Under PTAB

One reason the PTAB is convenient for reaching reverse payment deals is that there is no direct antitrust oversight, since its judges are administrators with very narrow …
By Erik Hovenkamp & Jorge Lemus
5 years ago 8

FTC charges Endo Pharmaceuticals with antitrust violations for pay for delay patent settlements

The FTC’s complaint alleges that Endo paid the first generic companies that filed for FDA approval – Impax Laboratories, Inc. and Watson Laboratories, Inc. – to eliminate the …
By Gene Quinn
5 years ago 6

In FY 2012, Branded Drug Firms Increased the Use of Pay-for-Delay Settlements to Keep Generic Competitors off the Market

In Fiscal Year (FY) 2012, the number of potentially anticompetitive patent dispute settlements between branded and generic drug companies increased significantly compared with FY 2011, jumping from 28 to 40, according …